1. Introduction {#sec1}
===============

We need to understand how proteins behave in order to manipulate them successfully. The means by which to achieve accurate, precise, and reproducible predictions of the key properties of therapeutically relevant proteins is a fundamental question in computational biology. Molecular dynamics (MD) simulations have been used to study complex biomolecular systems, but it is not possible to define how a system behaves from a single trajectory; single trajectory systems behave as Gaussian random processes, making the attainment of accurate predictions from a single run not a realistic proposition. Accurate predictions that correlate well with experimental data have been achieved with the use of multiple short MD simulations to enhance the sampling of conformational space and hence the convergence of observable properties.^[@ref1]−[@ref7]^ These ensemble-based fully atomistic MD studies have primarily focused on ligand-protein binding free energies, where there exists a wealth of experimental data with which to compare computational findings. In this paper, we take our first steps to assess the reliability and reproducibility of analogous CG-MD simulations. For this work, we have elected to examine the molecular nature of protein--protein interactions between G protein-coupled receptors (GPCRs). This is a biological system with which we are familiar experimentally.^[@ref8]−[@ref14]^

GPCRs are a particularly well-studied family of membrane proteins. Not only are they a large and important group of signaling proteins, they are also the targets for approximately 40% of all therapeutic compounds in clinical use. Although over 800 human proteins are classified as GPCRs, drugs have been developed against fewer than 10% of these targets.^[@ref15]^ Thus, there is huge potential to expand the number of targets for which new therapies can be designed. Novel therapeutic design is also important if one of the goals of personalized medicine, to develop new drugs for patient-specific variations of GPCRs, is to be achieved. Inclusion of functional GPCR homomers and heteromers in drug discovery programs also provides a means of expanding the range of novel targets for the development of therapeutic agents.^[@ref16]^ Originally believed to function as monomeric proteins, many functional GPCR oligomers have now been identified. Early examples include the obligate heteromeric assembly of GABA~B~R1 and GABA~B~R2 required to form a functional GABA~B~ receptor^[@ref17]^ and heterodimerization of the delta and kappa opioid receptor subtypes to form an opioid receptor with the κ~2~ receptor subtype pharmacology.^[@ref18]^ The archetypal class A GPCR rhodopsin forms structural dimers organized in paracrystalline arrays in membranes^[@ref19]^ and in the model crystal structure of this GPCR (1N3M).^[@ref20]^ For the design of cost-effective "designer" drugs for individuals that target receptor oligomers, it will be necessary to develop a powerful and sophisticated computational method for understanding the interactions involved in the formation of GPCR oligomers.

Biological methods for studying GPCR oligomers in native cells and tissues or in recombinant mammalian expression systems include coimmunoprecipitation, Western blot analyses, cross-linking studies, yeast two hybrid experiments, bimolecular fluorescence complementation via GFP reconstitution (BiFC), energy transfer-based methods (FRET and BRET), functional cross-talk, and activation by dimeric/bivalent ligands.^[@ref21]^ Unfortunately, these methods frequently allow for alternative interpretations of the results and therefore do not provide unequivocal answers regarding multimerization occurrence between candidate pairs of GPCRs nor do they yield specific details of the interface(s) between interacting GPCRs. Structural methods such as X-ray crystallography and atomic force microscopy could provide some of this information, but only three Class A GPCR dimer structures have been solved^[@ref22]−[@ref24]^ and tend to describe "contact areas" rather than specific molecular interfaces. For the development of an accurate computational model for analyzing GPCR interfaces, it is essential to have good experimental data with which to validate the model. Such data are made available for the A~2A~ adenosine receptor subtype, which has been shown to participate in the formation of both heteromeric^[@ref25]^ and homomeric GPCRs.^[@ref26]^ The identification of homomeric A~2A~ receptors provided an opportunity to identify the transmembrane domain (TM5) involved in self-association by far-UV CD spectroscopy and SDS-PAGE using synthetic peptides corresponding to the different transmembrane domains.^[@ref27]^ A subsequent study^[@ref28]^ mapped TM helix interactions in the A~2A~ receptor for 31 different peptide pairs. We have previously worked with the A~2A~ receptor gene^[@ref29]^ and are interested in identifying patient-specific variations within this and related nucleoside and nucleotide receptor subtypes.

There have been many computational studies of GPCR interactions (see [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). The methodologies for modeling these have, in general, adopted one of two approaches: (i) molecular dynamics simulations using models based on homology with the nearest related GPCR for which structural data exist or (ii) docking.^[@ref30],[@ref31]^ Initial GPCR MD studies were performed using CHARMM and AMBER, which were subsequently integrated into NAMD^[@ref32],[@ref33]^ and GROMACS.^[@ref34],[@ref35]^ Although there is no established standard protocol for MD simulations of GPCRs, a number have used GROMACS with the Martini force field,^[@ref36]−[@ref41]^ which is designed specifically for lipids and membranes and allows the lipid composition most suited to the receptor in question to be incorporated into the simulation. The more recent of the GPCR dimer modeling studies have been conducted using coarse-grained simulations, which take less compute time and therefore provide an opportunity to perform a substantial number of replicas for each set of simulation conditions.

###### Computational Methods Used for Modeling Mammalian GPCR Dimers

  type           GPCR dimers               method        force field    interface                          number of replicas                                                     time scale                           ref
  -------------- ------------------------- ------------- -------------- ---------------------------------- ---------------------------------------------------------------------- ------------------------------------ -------------------------------------
  homodimers     Rho/Rho                   docking       CVFF           TM4,5/TM4,5                                                                                               100 ps                               Filipek et al., 2004^[@ref63]^
                                                                                                                                                                                  ND[a](#t1fn1){ref-type="table-fn"}   Han et al., 2009^[@ref64]^
                                                                        TM1,2/TM1,2                                                                                               ND                                   Kaczor et al., 2013^[@ref65]^
                                           MD            Gromos-87      TM4,5/TM4,5                        1                                                                      45 ns                                Filizola et al., 2006^[@ref66]^
                                                         OPLSAA                                            1                                                                      0.1 μs                               Cordomí and Perez, 2009^[@ref67]^
                                                         Amber/parm99                                      2                                                                      300 ns                               Neri et al., 2010^[@ref68]^
                                           CG-MD         Martini        TM1,2, H8                          1[b](#t1fn2){ref-type="table-fn"}                                      8 μs                                 Periole et al., 2007^[@ref36]^
                                                                        TM4,5                              10                                                                     100 μs                               Periole et al., 2012^[@ref69]^
                                                                        TM6,7                                                                                                                                           
                 β~2~-/β~2~-adrenergic     CG-MD         Martini        H8/H8                              2                                                                      5 μs                                 Ghosh et al., 2014^[@ref41]^
                                                                        TM1/TM1                            4                                                                      ∼200 μs                              Prasanna et al., 2014^[@ref40]^
                                                                        TM4,5/TM4,5                        1[c](#t1fn3){ref-type="table-fn"}                                      ∼18 μs                               Mondal et al., 2013^[@ref39]^
                                                                        TM5/TM5                                                                                                                                         
                                                                        TM6/TM6                                                                                                                                         
                                                                        TM3/TM3                                                                                                                                         
                 β~1~-/β~1~-adrenergic     CG-MD         Martini        TM1/TM1                            3[d](#t1fn4){ref-type="table-fn"} (2 runs; different starting point)   2 μs                                 Mondal et al., 2013^[@ref39]^
                                                                        TM5/TM5                                                                                                                                         
                 α~1B~-/α~1B~-adrenergic   docking                      TM5/TM5                                                                                                   ND                                   Fanelli et al., 1999^[@ref70]^
                                                                        TM6/TM6                                                                                                                                         
                                                                        TM7/TM7                                                                                                                                         
                 5-HT~4~/5-HT~4~           docking                      TM2,4/TM2,4                                                                                               ND                                   Soulier et al., 2005^[@ref71]^
                                                                        TM4,6/TM4,6                                                                                                                                    Russo et al., 2007^[@ref72]^
                                                                                                                                                                                                                       Berthouze et al., 2007^[@ref73]^
                 5-HT~1A~/5-HT~1A~         docking       CHARMM         TM4,5/TM4,5                                                                                               15 ns                                Gorinski et al., 2012^[@ref74]^
                 CXCR4/CXCR4               docking                      TM4,5,IL2/TM4,5                                                                                           ND                                   Kaczor et al., 2013^[@ref65]^
                                           MD            OPLSAA         TM3/TM4,5                          1                                                                      50 ns                                Rodriguez et al., 2012^[@ref75]^
                                                                        TM5/TM5                                                                                                                                         
                 NTSR~1~/NTSR~1~           docking       CHARMM         TM1/TM4                                                                                                   ND                                   Casciari et al., 2008^[@ref76]^
                                                                        TM4/TM4                                                                                                                                         
                 δ-OR/δ-OR                 CG-MD         Martini        TM2,3,4/TM2,3,4                    1[e](#t1fn5){ref-type="table-fn"}                                      250 ns                               Provasi et al., 2010^[@ref37]^
                                                                        TM4/TM4 favored over TM4,5/TM4,5   2                                                                      1.5 μs                               Johnston et al., 2011^[@ref77]^
                 κ-OR/κ-OR                 docking                      TM1/TM2                                                                                                   ND                                   Kaczor et al., 2013^[@ref65]^
                 A~2A~R/A~2A~R             docking       CHARMM         TM1,2,3/TM1,2,3 TM1/TM1                                                                                   ND                                   Fanelli and Felline, 2011^[@ref78]^
                                                                        TM1,4/TM1,4                                                                                                                                     
                                                                        TM2,3/TM2,3                                                                                                                                     
                                                                        TM6,7/TM6,7                                                                                                                                     
                                                                        H8,I3/TM6                                                                                                                                       
                 A~3~R/A~3~R               MD            Amber7 FF99    TM4,5/TM4,5                        1                                                                      500 ps                               Kim and Jacobson, 2006^[@ref79]^
                 TXA~2~/TXA~2~             docking                      TM1/TM1                                                                                                   ND                                   Fanelli et al., 2011^[@ref80]^
                                                                        TM1/TM2,EL2                                                                                                                                     
                                                                        H8/H8                                                                                                                                           
                 D~2~R/D~2~R               Monte Carlo                  ND                                                                                                        ND                                   Woolf and Linderman, 2004^[@ref81]^
                 SSTR~1~/SSTR~1~           Monte Carlo                  ND                                                                                                        ND                                   Woolf and Linderman, 2004^[@ref81]^
                 LHR-LHR                   docking                      TM4/TM6,7                                                                                                 ND                                   Fanelli 2007^[@ref80]^
                                           MD            CHARMM         TM4/TM4                            1                                                                      1 ns                                 Fanelli 2007^[@ref80]^
                                                                        TM4/TM6                                                                                                                                         
                                                                        TM5/TM6                                                                                                                                         
                                                                        TM4/TM1,3                                                                                                                                       
  heterodimers   A~2A~R/D~2~R              docking                      TTM3,4/TM5,6                                                                                              ND                                   Canals et al., 2003^[@ref25]^
                                                                        TM3,4,5/TM4,5                                                                                                                                   
                                                                        TM4,5/TM3,4,5                                                                                                                                   
                 mGluR~2~/5-HT~2A~         docking                      TM4,5/TM4,5                                                                                               ND                                   Bruno et al., 2009^[@ref33]^
                                           MD            CHARMM22/27    TM4,5/TM4,5                        1                                                                      40 ns                                Bruno et al., 2009^[@ref33]^
                 μ-OR/δ-OR                 docking                      TM6,7/TM4,5                                                                                               ND                                   Liu et al., 2009^[@ref82]^
                                                                        TM1,7/TM4,7                                                                                                                                     
                                           MD            GROMOS87       TM1,7/TM4,5                        1                                                                      5 ns                                 Liu et al., 2009^[@ref82]^
                                                                        TM4,7/TM4,5                                                                                                                                     
  homotetramer   (V~2~R)~4~                MD            CHARMM22/27    TM3,4/TM4,7                        1                                                                      5 ns                                 Witt et al., 2007^[@ref32]^
                                                                        TM4,5/TM4,5                                                                                                                                     

ND: not defined, IL: intracellular loop, EL: extracellular loop.

Four different structures.

Nine different structures.

Two runs; different starting point.

Umbrella sampling of 43 different starting points.

When we began our studies, approximately 30 computational GPCR dimer models had been published ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). Of these, two are Monte Carlo-derived, 15 are based on docking, and nine have been generated using atomistic MD simulations. The rest are CG-MD models. Historically, docking was the earliest method to be employed and has been used regularly; its current use is widespread. Alternative methods of modeling began with Monte Carlo methods, moving to fully atomistic MD and a subsequent shift to CG-MD, which is the predominant MD method currently in use for GPCRs. CG-MD is popular as it is cheaper and faster and has been shown, when CG models are subsequently converted to atomistic representations, to produce similar results to models generated by atomistic MD.^[@ref38],[@ref42],[@ref43]^ CG-MD simulations have also been used to study TM helix--helix dimers for non-GPCR types of cell surface receptors such as Glyphorin A and ErbB dimers.^[@ref44],[@ref45]^

GPCRs exhibit thermodynamic equilibrium states and therefore are "mixing" in the language of ergodic dynamical systems theory.^[@ref5]^ Neighboring trajectories diverge exponentially, and only probabilistic descriptions are meaningful. For these intrinsic reasons, collections of trajectories differing only in their initial conditions, known as ensembles, are the best means of studying the properties of such systems. Each individual system in the ensemble is referred to as a replica. As an additional benefit, performing such ensemble-based molecular dynamics simulations provides close control of errors and uncertainties in predictions. In this paper, we present the development of a robust and rapid method of this kind for identifying helix--helix interactions in GPCRs.

2. Methods {#sec2}
==========

Here, we aim to develop a consistent, rapid, reproducible CG-MD methodology for the study of interacting helices. This method involves placing two GPCR transmembrane helices (a simulation set) in a membrane and running simulations with the hope of identifying interactions between the helices. In these simulations, we will be using distance as a means of identifying two different types of interactions: interactions between helices and interactions between amino acid residues on each helix. For the successful identification of both types of interactions, it is necessary to specify the number of replicas (identical independent simulations other than for the initial velocity seeds assigned to the particles) and the run time needed to achieve converged results and see how well they reproduce experimental results. The number of replicas must be sufficient to achieve a reproducible result as evidenced by a sufficiently small error estimate.

We will use the terms "stable dimer" and "dimerization" to refer to interactions between helices. A 10 Å truncation cutoff (backbone to backbone) has been set for dimerization, as it has been shown experimentally that a unique FRET signal is generated when two labeled peptides are located within 10 Å of each other and form an excited stated dimer.^[@ref46]^ The term "specific interactions" will be used to refer to interactions between amino acid side chains on the dimerized helices. Specific interactions will be identified from contact matrices (heat maps). Although a 12 Å truncation cutoff had previously been used to analyze these interactions,^[@ref47]^ we will set our interaction cutoff to 10 Å because the existence of hydrogen bond (C~α~-H^\...\...^O) contacts as a function of the interhelical axial distance is between 6 and 12 Å. Side chain to side chain distances consistent with this are used to identify specific interactions with distances of 5--7 Å reflecting stronger interactions.

From [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, it can be seen that the longest total simulation time for atomistic MD is 0.1 μs and for CG simulations is 200 μs. The formation of a long-lasting helix dimer was identified within a few hundred nanoseconds in CG-MD studies of Glocophorin A, a non-GPCR model for studying TM membrane protein structure.^[@ref23]^ The number of replicas performed in these different studies varies tremendously but is never greater than 10. Excellent agreement has been obtained between computed binding free energies and experimental data when ensembles of up to 50 replicas are used.^[@ref1]^ We therefore selected 500 ns for the run time and 50 replicas as starting parameters for these studies. These calculations were run on Legion and Grace, two high-performance Research Computing clusters at University College London (UCL) (details of the machines used can be found at <https://wiki.rc.ucl.ac.uk/wiki/RC_Systems#Legion_technical_specs> and <https://wiki.rc.ucl.ac.uk/wiki/RC_Systems#Grace_technical_specs>). Our preliminary tests showed that CG simulations (one ensemble) of 500 ns run on Legion completed within approximately 150 h. CG simulations (one ensemble) of 500 ns run on Grace completed within approximately 72 h.

2.1. CG Simulations {#sec2.1}
-------------------

All CG-MD simulations were performed in GROMACS (version 4.6.4) ([www.gromacs.org](www.gromacs.org)). The temperature was equilibrated for all three groups: protein, lipid bilayer, and solvent (water) with ions to remove the center of mass motion relative to the bilayer and protein. The thermalization run was carried out for 100 ps. The simulations were then run at 310 K (the human physiological temperature), which is below the phase transition temperature of pure DPPC (315 K). The system output of the temperature was evaluated to ensure that it stabilized at the required temperature (310 K) before continuing until pressure equilibration was attained. An ensemble of 50 replicas for each simulation box (see [Tables [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"} and [4](#tbl4){ref-type="other"}) was performed. Each simulation was run for 500 ns. CG atom velocities were drawn from a Maxwell--Boltzmann distribution at *T* = 310 K, but all other variables were kept constant; standard deviation was used to compare differences in mean distance outputs. Each simulation was run independently with the initial configurations differing by only the starting velocity; they were performed under the NPT ensemble (i.e., constant temperature, pressure, and particle number) using the Martini 2.2 force field.^[@ref48]^ The temperatures of the protein and lipid were coupled using the velocity-rescaling (modified Berendsen) thermostat at 310 K (human physiological body temperature) with a coupling constant of *T*~*t*~ = 1 ps. The system pressure was semi-isotropic using the Berendsen algorithm at 1 bar with a coupling constant of *T*~*p*~ = 1 ps and a compressibility of 1 × 10^--4^ bar^--1^. An integration time step of 30 fs was chosen, and the coordinates were saved every 10000 subsequent steps for further analysis. The electrostatic interactions were shifted to zero between 1.0 nm. The Lennard-Jones (LJ) potential was shifted to zero between 0.9 and 1.2 nm to reduce the cutoff noise. The neighbor list for pairwise nonbonded interactions was determined by the Verlet cutoff scheme at 1.4 nm and updated every 10 steps.

###### Sequences of the A~2A~R Helices Used in Ensemble Simulation Sets

  A~2A~R helices    sequence[a](#t2fn1){ref-type="table-fn"}
  ----------------- ---------------------------------------------------------
  TM2-wild-type     FVVSLAAA*D52^**2.50**^*IAVGVLAIPFAITI
  TM5-wild-type     **MNYM**VYFNFFACVLV*P189^5.50^***LLLM**LGVYLRI
  TM5-M177^5.38^A   **MNY***[A]{.ul}*VYFNFFACVLV*P189^5.50^***LLLM**LGVYLRI
  TM5-M193^5.54^A   **MNYM**VYFNFFACVLV*P189^5.50^***LLL***[A]{.ul}*LGVYLRI
  TM5-M193^5.54^I   **MNYM**VYFNFFACVLV*P189^5.50^***LLL***[I]{.ul}*LGVYLRI

Residues suggested to play a key role in the dimerization of the A~2A~R TM5 helix^[@ref27]^ are indicated in bold; mutated residues are underlined and italicized. The conserved amino acid for each TM helix is italicized and is numbered using both the Ballesteros and Weinstein nomenclature (superscript) and by residue number.

2.2. Dimer Analysis {#sec2.2}
-------------------

Interhelix distance matrices were calculated for the helix--helix dimer formation and contact maps used to identify specific interactions between residues were generated using the GROMACS tool g_mdmat. The individual helix--helix contacts from each replica were examined by calculating the resulting interhelix distance matrices from the initial simulation starting distance of 4 nm (40 Å) to assess the reproducibility, number of replicas, and run time needed to achieve convergence through a locally written code. In those runs where dimerization was observed, the trajectories were combined and examined in greater depth by calculating the averaged interhelix distance matrices with three different truncation distances of 10, 12, and 15 Å to determine the dimerization properties between the helices. A cutoff distance of 10 Å was then applied to identify residues involved in helix--helix interactions. To investigate the influence of the number of replica simulations on the reliability of our results, we calculated mean interaction distances for ensembles of varying size. For evaluations of run length, mean distance output for the entire ensemble was calculated at 100 ns increments.

Representative atomistic structures of the different CG dimers were generated through use of the "backward" Python script^[@ref49]^ and the g_cluster tool in GROMACS using the gromos algorithm at a cutoff of 2.5 nm.^[@ref50]^ Visualization was performed using VMD.^[@ref51]^ Approximate distances between the atomistic residues in interacting helices were measured using Jmol ([www.jmol.org](www.jmol.org)). Amino acid positions have been described using amino acid number in conjunction with the Ballasteros--Weinstein nomenclature^[@ref52]^ (in superscript). Pairwise combinations used in the analyses were obtained from a matrix of the number of amino acid residues in helix 1 multiplied by the number of amino acid residues in helix 2. In the A~2A~ receptor, there are 729 possible pair combinations between the two 27 residue long TM5 helices; for example, combination 552 specifies the combination of residue 23 (helix 1) with residue 24 (helix 2), representing the V196^5.57^--Y197^5.58^ interaction.

2.3. Construction of A~2A~R TM Helices and Preparation of the Simulation Box {#sec2.3}
----------------------------------------------------------------------------

Initial simulations were performed using TM5 of the human A~2A~ adenosine receptor, which has been shown experimentally to form a homodimer.^[@ref28]^ TM2 of the A~2A~ receptor was used as a negative control as it was unable to form a homodimer under the same experimental conditions. M193^5.54^, identified experimentally as being involved in the helical interface and located within a PXXXM motif, and M177^5.38^, which we identified as residing in a previously unidentified upstream PXXXM motif, were mutated in silico (M177^5.38^A, M193^5.54^A, and M193^5.54^I), to permit simulation of the experimental condition in which M193^5.54^ had been mutated and the biological properties of the mutated protein compared with wild type.

The five A~2A~ TM helices shown in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"} were generated using MODELLER 9.12 following the procedure detailed^[@ref53],[@ref54]^ using the crystal structure of the A~2A~ receptor (PDB accession number 3EML; GI: 209447557).^[@ref55]^ The atomistic helices were subsequently converted to CG models using the "martinize" Python script.^[@ref43]^ A simulation box of dimensions 8 nm × 8 nm × 8 nm was constructed containing two wild-type TM5 helices ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). The helices were placed 4 nm apart and aligned in a parallel orientation mimicking the natural positioning of the helix in the membrane (see [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}a) with their long axes parallel to the *z*-axis of the box (see [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}b). The TM helices were separated by 4 nm at the beginning of the simulation to rule out any initial interhelix interactions. Water and lipids were then added. Approximately 190 molecules of the 1,2-dipalmitoyl-*sn*-glycero-3-phosphocholine (DPPC) lipid bilayer and additional water molecules (∼2660--2690) were added in coarse-grained form in a 3-dimensional cuboid box with periodic boundary conditions using the "insane" Python script.^[@ref56]^ For neutralization of the net charge on the protein, water molecules were replaced by counterions (either Na^+^ or Cl^--^, as appropriate, depending on the amino acid composition of the helices).

![Experimental system showing (a) a schematic representation of the A~2A~ receptor structure indicating the directionality of the TM helices within the lipid bilayer and (b) placement of the TMs within the simulation box prior to the addition of lipid and water.](ct-2016-01246g_0001){#fig1}

3. Results {#sec3}
==========

Our aim is to investigate the computational parameters required to obtain converged results, to identify whether these results match the experimentally obtained data for the self-association of the TM5 helices of the A~2A~ adenosine receptor, and if they do, to further validate these parameters using structural biology data from class A GPCRs that have been experimentally shown to form a dimeric biological unit.

3.1. Internal Sampling, Convergence, and Reproducibility {#sec3.1}
--------------------------------------------------------

In our simulations, the TM helices were observed to diffuse freely in the lipid bilayer. The kernel density estimation of the mean distance between the two wild type TM5 helices at *t* = 0 and at increments of 100 ns up to completion of the simulation at 500 ns across the 50 replica ensemble is shown in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}. At *t* = 0, the two helices are at their starting positions 40 Å (4.0 nm) apart. At *t* = 500 ns, the mean distance between the helices has adopted a normal distribution with a mean distance of ∼16 Å between them. The intermediate time points show the redistribution of the distance from the starting point at *t* = 0 to the final mean distance between the helices at 500 ns. A graphical representation of the number and timing of interactions observed in each replica within the ensemble of 50 replicas for the wild-type TM5--TM5 simulation is shown in [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}. Four of the 50 replicas showed no contact between the helices, which gives rise to the small peak at 40 Å in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}. Three of the replicas began to show contact toward the end of the run, which corresponds to the smaller peak seen at 30 Å in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}.

![Distribution of the mean distance between the two TM5--TM5 wild type helices at 0, 100, 200, 300, 400, and 500 ns in all 50 replicas.](ct-2016-01246g_0002){#fig2}

![Number and timing of pairwise interactions for each of the 50 replicas within the wild-type TM5--TM5 dimer ensemble are shown. The *x* and *y* axes are linear and represent run length from 0 to 500 ns and the number of interaction events from 0 to 250 counts, respectively.](ct-2016-01246g_0003){#fig3}

### 3.1.1. Optimal Replica Number Required {#sec3.1.1}

Five different ensembles, one for each A~2A~ receptor simulation set, were run independently in CG-MD simulations for the total run time of 500 ns. These data, which included both wild type and mutated helix sequences, were used to investigate whether variations in the optimal replica number required would occur between different simulation sets. This information was used to identify the minimum replica number required to achieve convergence for any given simulation set.

[Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}a reveals that there is no statistically significant difference in the mean distance as a function of replica number. However, a decrease in the error of the mean is observed with increasing ensemble size. From [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}b it can be seen that the rate of decrease in the error slows after approximately 15 replicas are included in the ensemble. For each of the five sets, larger ensembles provide less variation in the error of the mean, and an ensemble of 30 replicas represents a good compromise between computational effort and minimization of the error in the mean distance calculated. We conclude that an ensemble of 30 replicas is sufficient to achieve convergence.

![Variation in (a) the mean distance between TM helices and (b) the error (standard deviation) is shown as a function of the number of replicas performed for the following simulation sets: (blue circle) wild-type TM5--TM5 helices, (black square) M177A-mutated TM5--TM5 helices, (red triangle) M193A-mutated TM5--TM5 helices, (green inverted triangle) M193I-mutated TM5--TM5 helices, and (purple diamond) wild-type TM2--TM2 helices.](ct-2016-01246g_0004){#fig4}

### 3.1.2. Minimum Run Length Required {#sec3.1.2}

The effect of run time on the average distance between the helices was examined by calculating the mean distance and the standard deviation within the 50 replicas for simulations of varying duration (0, 100, 200, 300, 400, and 500 ns). [Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}a shows a significant effect of run length on both mean distance and standard deviation, confirming the results of [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"} and reflecting the time required for interactions to take place. For four of the five simulation sets, the standard deviation increases as a function of time with the rate of increase slowing as the run length becomes longer. In contrast, no change in the standard deviation over time is seen in the TM2--TM2 set ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}b). Interestingly, TM2 homodimers could not be detected experimentally.^[@ref57]^ The absence of an increase in error in the mean distance as a function of time may serve as an indicator of an absence of interaction between two helices within an ensemble. We conclude that an ensemble run for a simulation time of 300 ns is sufficient to achieve convergence.

![Variation in (a) the mean distance between TM helices and (b) the error (standard deviation) is shown as a function of the run length for the following simulation sets: (blue circle) wild-type TM5--TM5 helices, (black square) M177A-mutated TM5--TM5 helices, (red triangle) M193A-mutated TM5--TM5 helices, (green inverted triangle) M193I-mutated TM5--TM5 helices, and (purple diamond) wild-type TM2--TM2 helices.](ct-2016-01246g_0005){#fig5}

3.2. Interacting Interfaces {#sec3.2}
---------------------------

The final mean distance between the two helices in the ensemble of 50 replicas was used to identify the specific interactions between the A~2A~ homodimers for each simulation set tested. Following application of the 10 Å cutoff, 26% of the ensemble formed stable dimers in the wild-type TM5--TM5 simulations. In the mutated TM5-M177^5.38^A and TM5-M193^5.54^I simulation sets, 16% of the ensemble formed stable dimers, whereas in TM5-M193^5.54^A, dimers were detected in 28% of the ensemble. For all four of the TM5 simulation sets, the detected interactions took place at the same position within the helices, indicating that a defined orientation is needed to establish a specific interaction. In the negative control (the TM2--TM2 simulation set), 24% of the ensemble resulted in the formation of stable dimers, but there were no specific interactions identified between residues. For all simulations, we combined the trajectories of those pairwise combinations in which dimerization was identified after the cutoff of 10 Å had been applied and compared the results with heat maps of interactions observed at 12 and 15 Å (see [Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}). The location of the contact interface was then mapped by comparison with the crystal structure of A~2A~R (3EML).

![Contact matrices (heat maps) showing specific interactions between residues, as measured by distance, between two A~2A~ helices ("helix 1" and "helix 2") for the wild-type TM5--TM5 simulation (a--c) and the TM2--TM2 negative control (d--f). Results shown are the average for each ensemble. Interhelical distances at the 15 Å cutoff are shown in the top left quarter of panels (a) and (d). Interhelical distances at the 12 Å cutoff are shown in the top left corner of (b) and (e) and in the lower right quarter of panels (a) and (d). Interhelical distances at the 10 Å cutoff are shown in the lower right quarter of panels (b) and (e). The region shown in the black rectangle in (a) and (d) is magnified in (c) and (f), respectively. The five numbered interactions shown in (c) are identified in [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}. The color scale indicates distance between helices: blue corresponds to 0 Å (superposition of the two helical backbones at all cutoffs); green corresponds to 5 Å (10 Å cutoff), 6 Å (12 Å cutoff), and 7.5 Å (15 Å cutoff); yellow corresponds to 7 Å (10 Å cutoff), 8 Å (12 Å cutoff), and 12 Å (15 Å cutoff); red corresponds to the cutoff distances applied (10, 12, or 15 Å).](ct-2016-01246g_0006){#fig6}

### 3.2.1. Identification of Contact Interface for the Wild-Type TM5--TM5 Homodimer {#sec3.2.1}

[Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"} shows the average interhelical contact distance between the two wild-type TM5--TM5 helices ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}a--c) or between the negative control TM2--TM2 helices ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}d--f). The proximity of the wild-type helices is best visualized at 15 Å ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}a and c). The interacting residues in the wild-type TM5--TM5 simulation are found in the bottom third of the C terminal end of TM5. From the averaged interhelix contact matrices, the specific interactions were found to be within the experimentally identified M193^5.54^*xx*VY197^5.58^ motif at an interhelical distance of ∼8--9 Å. The methionine at position 193^5.54^ of helix 1 interacts with the methionine at the same position on helix 2, reinforcing the suggestion^[@ref27]^ of its importance in the formation of the TM5 homodimer. From [Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}d it can be seen that the distance between TM2--TM2 is close enough to form potential specific interactions; however, none were detected in the combined trajectories for this negative control. Results obtained at the 15 Å cutoff ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}f) were random and nonspecific, supporting the selection of a minimum cutoff distance of 12 Å. It should also be noted that there was no increase in the standard deviation over time for the TM2--TM2 simulation ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}b), whereas there was an increase in this quantity for all simulation sets in which specific interactions occurred, indicating that the change in error over time may be a useful indicator of helix--helix interactions. The frequency of specific interactions identified in the wild-type TM5--TM5 ensemble was determined by calculating the mean distance for each frame of every replica individually. [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"} shows that the five most prominently occurring interactions were between M193^5.54^--M193^5.54^~,~ V196^5.57^--Y197^5.58^, Y197^5.58^--R199^5.60^, R199^5.60^--R199^5.60^, and R199^5.60^--I200^5.61^.

###### Number of Interactions (Hits) for Specific Interacting Residues Identified in the Contact Matrices for the Wild-Type TM5--TM5 Simulation at the 10 Å Cutoff

                               replica number                                             
  --- ------------------------ ---------------- --- --- --- --- --- --- --- --- ---- ---- -------------
  1   M193^5.54^--M193^5.54^   0                0   1   1   1   2   2   3   5   6    6    7.59 ± 2.89
  2   V196^5.57^--Y197^5.58^   0                1   2   2   2   4   4   6   9   12   13   9.16 ± 2.5
  3   Y197^5.58^--Y197^5.58^   0                1   1   1   1   1   2   4   6   7    8    9.11 ± 2.85
  4   Y197^5.58^--R199^5.60^   0                1   1   1   1   1   1   3   5   6    6    9.83 ± 3.57
  5   R199^5.60^--R199^5.60^   0                1   1   1   1   1   1   3   4   5    5    8.06 ± 2.99

These findings are consistent with the experimental results^[@ref27]^ identifying that the interaction between two wild-type A~2A~ TM5 peptide sequences involved amino acid residue M193^5.54^. Our findings are also consistent with experimental data showing the formation of A~2A~ receptor homodimers using bioluminescence resonance energy transfer (BRET)^[@ref26]^ and bimolecular fluorescence complementation (BiFC).^[@ref58]^ The presence of specific interactions between TM2 helices was experimentally investigated, and none were detected.^[@ref27],[@ref57]^ Our CG-MD simulations produced the same results as the experimentally obtained findings with the formation of wild-type TM5--TM5 dimers involving the M193^5.54^ residue, and no specific interaction was detected between TM2--TM2 helices in silico.

### 3.2.2. Mutated TM5 Interacting Interfaces {#sec3.2.2}

Identification of the presence of M193^5.54^ in the contact interface suggested that this residue may play a significant role in how the two TM5 helices interact. To investigate this possibility, we introduced sets of ensemble simulations that included mutated helices (see [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). Two types of point mutations were used: substitution of (i) methionine to alanine and (ii) methionine to isoleucine. Investigation of the TM5 peptide sequence revealed that two separate P*xxx*M motifs existed within the same helix with a methionine residue present at M177^5.38^ as well the methionine residue identified at M193^5.54^. Each of these methionine residues was mutated to alanine. We also mutated M193^5.54^ to isoleucine because a conserved P*xxx*I motif is found in the related family of P2Y receptors at the same location as the originally identified P*xxx*M motif in A~2A~R.

Specifically interacting residues in the TM5-M177A simulation set were identical to those identified in wild type TM5--TM5 dimers ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}a) and included the M193^5.54^*xxx*VY197^5.58^ motif. M177^5.38^ was not directly involved in the dimerization between the two helices in any simulation. The specific interactions observed in the TM5-M193I^5.54^ simulation set were almost identical to those found in the wild-type but included I193^5.54^ in the interaction despite the loss of the methionine at position 193 ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}b). In contrast, the TM5-M193A^5.54^ mutation completely changed the contact interface of the helices ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}c), and the key interacting residues were identified at a similar distance but contained within a novel V196^5.57^Y*x*R199^5.60^ motif. This provides a molecular explanation for the finding that mutation of the full-length A~2A~R at position M193^5.54^ noticeably alters the monomer:dimer ratio as observed with SDS-PAGE.^[@ref27]^ Mutation of M193A^5.54^ causes a change in the way in which the two helices come together that prevents formation of TM5 homodimers, emphasizing the importance of the M193^5.54^ residue in the specificity of TM5--TM5 dimer formation in vivo.

![Contact matrices (heat maps) showing specific interactions between two mutated A~2A~ TM5 helices ("helix 1" and "helix 2") with the following residues mutated: M177A (a), M193^5.54^A (b), and M193^5.54^I (c). Results shown are the average for each ensemble. Interhelical distances at the 15 and 12 Å cutoff distances are shown in the top left and lower right quarter of panels (a--c), respectively. The color scale is as indicated in [Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}. Circles indicate areas with key interhelical contacts. The identified amino acid interactions are numbered as follows: (1) M193^5.54^ with M193^5.54^; (2, 3) V196^5.57^ with Y197^5.58^ and Y197^5.58^ with Y197^5.58^; (4) Y197^5.58^ with I200^5.61^ and R199^5.60^ with R199^5.60^; (5) L192^5.53^ with I193^5.54^, V196^5.57^ with Y197^5.58^, and Y197^5.58^ with R199^5.60^, (6) Y197^5.58^ with I200^5.61^ and Y197^5.58^ with R199^5.60^; and (7) R199^5.60^ with R199^5.60^.](ct-2016-01246g_0007){#fig7}

3.3. Comparison with Experimental Structural Data {#sec3.3}
-------------------------------------------------

For assessing the validity of our method, it is necessary to compare our results with experimental values. Our computational results closely match the experimental biophysical data of A~2A~ receptor homodimers and provide information regrading the nature of the contact interface between the two helices that cannot be determined experimentally. We then wished to determine if we could obtain findings in agreement with experimentally obtained structural data. Dimerization in Class A GPCRs involves the transmembrane domains, as opposed to Class C GPCRs, where dimerization is mediated by the large N terminal domain of the protein.^[@ref59]^ We identified three additional dimeric Class A GPCRs in the PDB database that fulfilled the following criteria: (1) the crystallographic asymmetric unit is a dimer; (2) the software-determined (PISA) quaternary structure is a dimer; and (3) the dimeric quaternary structure has been confirmed functionally. Rhodopsin, the CXCR4 chemokine receptor, and the β~1~ adrenergic receptor were chosen for further study; their corresponding TM helices (listed in [Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}) were constructed as described in [section [2.3](#sec2.3){ref-type="other"}](#sec2.3){ref-type="other"} and used in ensemble-based simulations.

###### Sequences of the Rhodopsin, CXCR4, and β~1~AR Receptor Helices Used in Ensemble Simulation Sets

  receptor    helices   sequences[a](#t4fn1){ref-type="table-fn"}
  ----------- --------- -----------------------------------------------
  rhodopsin   TM1       QFSMLAAYMFLLIMLGFPI*N^**1.50**^(55)*FLTLYVTVQ
              TM2       NYILLNLAVA*D^**2.50**^(83)*LFMVFGGFTTTLYTSLH
              TM4       ENHAIMGVAFT*W^**4.50**^(161)*VMALACAAPPL
              TM5       NESFVIYMFVVHFII*P^**5.50**^(215)*LIVIFFCYGQ
  CXCR4       TM5       VVVFQFQHIMVGLIL*P^**5.50**^(211)*GIVIL
              TM6       VILILAFFACWL*P^**6.50**^(254)*YYIGISI
  β~1~AR      TM1       QWEAGMSLLMALVVLLIVAG*N^**1.50**^(59)*VLVIAAIG
              TM2       NLFITSLACA*D^**2.50**^(87)*LVMGLLVVPFGATLVV
              TM4       ARAKVIICTV*W^**4.50**^(166)*AISALVSFLPIMM
              TM5       AYAIASSIISFYI*P^**5.50**^(219)*LLIMIFVYLRVY

The conserved amino acid for each TM helix is shown in italics and is numbered using both the Ballesteros and Weinstein nomenclature (superscript) and by residue number.

### 3.3.1. Rhodopsin (1N3M) {#sec3.3.1}

Rhodopsin has been shown to exist in a native oligomeric form,^[@ref20]^ and an atomic model of the rhodopsin dimer has been proposed as a working model for G protein-coupled receptors.^[@ref19]^ Three contact points between the rhodopsin monomers have been reported. The first is considered to be the strongest with the largest contact area (578 Å^2^) and is located between TM4 and TM5. The second exhibits a contact area of 333 Å^2^ and is located between TM1 and TM2. The third contact point is considered the weakest interaction and is found between rows of dimers at the extracellular ends of TM1 with a contact area of 146 Å^2^.^[@ref19],[@ref22]^ We ran two heterologous simulations between rhodopsin helices TM1 and TM2 and between rhodopsin helices TM4 and TM5 (see [Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}) to identify whether contact interfaces could be identified for either. [Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"} shows that, for both simulation sets, stable dimers were established, confirming that our computational method is able to produce results in agreement with structural data. In each case, the mean distance between helices was ∼7.6--8 Å. The mean distance between specific interacting residues in the TM1--TM2 simulation ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}a) is further apart than the mean distance between specific interacting residues in the TM4--TM5 simulation ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}b).

![Contact matrices (heat maps) between two rhodopsin helices, showing specific interactions between TM1 (helix 1) and TM2 (helix 2) (a) and between TM4 (helix 1) and TM5 (helix 2) (b). Results shown are the average for each ensemble. The color scale is as indicated in [Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}. Circles indicate areas with key interhelical contacts. The identified amino acid interactions are numbered as follows: (1) F127^1.47^ with L218^2.44^; (2) L122^1.42^ with L220^2.46^, I123^1.43^ with L218^2.44^, and N219^2.45^ with L220^2.46^; (3) Y118^1.38^ with D224^2.50^, M119^1.39^ with D224^2.50^, F120^1.40^ with D224^2.50^, and F120^1.40^ with L225^2.51^; (4) F418^4.48^ with L521^5.51^ and T419^4.49^ with L521^5.51^; (5) F418^4.48^ with F525^5.55^; (6) M414^4.44^ with F525^5.55^, G415^4.45^ with F525^5.55^, and V416^4.46^ with F525^5.55^; (7) H411^4.41^ with Y528^5.58^, H411^4.41^ with G529^5.59^, and H411^4.41^ with Q530^5.60^.](ct-2016-01246g_0008){#fig8}

### 3.3.2. CXCR4 (3ODU) {#sec3.3.2}

The crystal structure of the CXCR4 chemokine receptor bound to an antagonist small molecule IT1t has been reported and reveals a homodimer with an interface involving TM helices 5 and 6.^[@ref23]^ We investigated interactions between helices in the CXCR4 receptor and identified the formation of stable dimers with specific interactions ([Figure [9](#fig9){ref-type="fig"}](#fig9){ref-type="fig"}). We first ran a heterologous simulation between TM5 and TM6 and were unable to identify any interactions. CXCR4 is able to form homodimers in the absence of ligand^[@ref60]^ that are unable to be dissociated by a peptide derived from TM6,^[@ref61]^ suggesting that in unliganded CXCR4, the dimer interface may reside between TM5 and TM5 in a manner analogous to the A~2A~ receptor. We then ran a CXCR4 TM5--TM5 simulation and identified, from the averaged interhelix contact matrices, the formation of dimers with specific interactions between F201^5.40^ and the following six residues: V198^5.37^, Q200^5.39^, F201^5.40^, Q202^5.41^, I204^5.43^, and M205^5.44^.

![Contact matrices (heat maps) between two CXCR4 helices, showing specific interactions (a) between TM5 (Helix 1) and TM6 (Helix 2) and (b) between TM5 (Helix 1) and TM5 (Helix 2). The identified amino acid interactions are numbered as follows: 1) F201^5.40^ with V198^5.37^, Q200^5.39^, F201^5.40^, Q202^5.41^, I204^5.43^ and M205^5.44^. [Table [5](#tbl5){ref-type="other"}](#tbl5){ref-type="other"} shows a comparison of the distances between specific atoms in interacting residues of the representative structures and the distances between the same atoms in the model structure.](ct-2016-01246g_0009){#fig9}

### 3.3.3. β~1~-Adrenergic Receptor (4GPO) {#sec3.3.3}

Two alternating dimer interfaces have been proposed from the crystal structure of the ligand-free basal state of the β~1~ adrenergic receptor (β~1~AR). The first involves TM1, TM2, extracellular loop 1, and the C-terminal H8; the second involves TM4 and TM5.^[@ref24]^ We ran two heterologous simulations between β~1~AR helices TM1 and TM2 and between β~1~AR helices TM4 and TM5 (see [Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}) to identify whether contact interfaces could be identified for either. No stable dimers were formed in the TM1--TM2 simulation ([Figure [10](#fig10){ref-type="fig"}](#fig10){ref-type="fig"}a). We investigated the possibility that the contact interface was formed between the two TM1 helices. We ran a TM1--TM1 simulation and identified a stable dimer in only one replica in the ensemble ([Figure [10](#fig10){ref-type="fig"}](#fig10){ref-type="fig"}b). Stable dimers were formed between TM4 and TM5 with specific interactions identified between L159^4.43^ and Y231^5.58^ and between W166^4.50^ and Y277^5.62^ ([Figure [10](#fig10){ref-type="fig"}](#fig10){ref-type="fig"}c).

![Contact matrices (heat maps) between two β~1~AR helices showing specific interactions between (a) TM1 (helix 1) and TM2 (helix 2), (b) TM1 (helix 1) and TM1 (helix 2), and (c) between TM4 (helix 1) and TM5 (helix 2) (c). Results shown are the average for each ensemble. The color scale is as indicated in [Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}. Circles indicate areas with key interhelical contacts. The identified amino acid interactions are numbered as follows: in (a) (1) W40^1.31^ with A42^1.33^, S45^1.36^, and L46^1.37^; (2) M44^1.35^ with L46^1.37^; (3) A49^1.39^ with M48^1.38^; (4) L53^1.44^ with M48^1.38^; (5) L53^1.44^ with M48^1.38^, V51^1.40^, and V52^1.41^; (6) L54^1.45^ with V51^1.40^; (b) (1) K159^4.43^ with Y231^5.58^ and (2) W166^4.50^ with Y227^5.62^. [Table [5](#tbl5){ref-type="other"}](#tbl5){ref-type="other"} shows a comparison of the distances between specific atoms in interacting residues of the representative structures and the distances between the same atoms in the model structure.](ct-2016-01246g_0010){#fig10}

3.4. Atomistic Representation and Proposed Nature of Interactions {#sec3.4}
-----------------------------------------------------------------

In CG simulations, a small group of atoms is treated as a single particle (in a 4:1 ratio), a representation that lacks the specific details needed to describe the nature and type of interactions that might take place when the two TM helices are within 10 Å of each other. Representative atomistic structures were generated from CG models to enable a measurement of distance between atoms,^[@ref49]^ allowing hypotheses to be drawn regarding the molecular nature and possible role of the interactions between dimeric helices.

[Figure [11](#fig11){ref-type="fig"}](#fig11){ref-type="fig"} shows a representation of the converted atomistic wild-type A~2A~ TM5 dimer. Using this atomistic representation, the presence of possible electrostatic interactions or hydrogen bonding was investigated by measuring the distance between the specific interacting residues. The interaction between the two methionine residues (M193^5.54^--M193^5.54^) and between valine and tyrosine (V196^5.57^--Y197^5.58^) is likely to correspond to van der Waals interactions. Y197^5.58^ in helix 1 and Y197^5.58^ in helix 2 each interact as hydrogen donor and acceptor in the dimer, forming bonds between the peptide backbone and the tyrosine side chain (see [Figure [11](#fig11){ref-type="fig"}](#fig11){ref-type="fig"}). As the measurement of these distances is longer than the optimal hydrogen bond distance, 2.7 Å, such hydrogen bonds are more likely to be formed backbone-to-side-chain because their interhelical distance of 8 Å is above the 7.6 Å limit of backbone-to-backbone interactions.^[@ref47]^

![Atomistic representation of the pairwise interactions identified from the wild-type TM5--TM5 ensemble. The representative mean distance is shown in the figure, and the mean distance ± SD for all hits detected per pair is shown in [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}. All distances between interacting amino acids are calculated from side chain to side chain.](ct-2016-01246g_0011){#fig11}

The rhodopsin dimer model (1N3M), shown in [Figure [12](#fig12){ref-type="fig"}](#fig12){ref-type="fig"}a, reveals that there is a greater interface area between TM4 and TM5 than between TM1 and TM2. The specific interacting residues identified from the atomistic representation obtained using our computational method are distributed throughout the length of TM1 and TM2 but restricted to the bottom third of TM4 and TM5 with respect to the intracellular face of the receptor ([Figure [12](#fig12){ref-type="fig"}](#fig12){ref-type="fig"}b--e). A comparison of our results with the TM1 and TM2 contact interface of 1N3M is shown in [Figure [12](#fig12){ref-type="fig"}](#fig12){ref-type="fig"}b and c, respectively. The measured distance between the hydrogen on the COOH group of M119^1.39^ and the double-bonded oxygen of the COOH group on the side chain of D224^2.50^ is 10.32 ± 3.21 Å in our model ([Figure [12](#fig12){ref-type="fig"}](#fig12){ref-type="fig"}b), similar to 9.01 Å in 1N3M ([Figure [12](#fig12){ref-type="fig"}](#fig12){ref-type="fig"}c). Measurement of the distance between F127^1.47^ and L218^2.44^ is 14.20 ± 4.07 Å in our model and 15.28 Å in 1N3M. F127^1.47^ and L218^2.44^ are located toward the bottom of their respective helices, a position that is constrained by the first intracellular loop of rhodopsin in 1N3M but not in our model. Similar conservation of distance was identified between interacting residues in TM4 and TM5 (see [Table [5](#tbl5){ref-type="other"}](#tbl5){ref-type="other"}).

![(a) Atomistic structure of the rhodopsin dimer model (1N3M) viewed from above with the TMs used for simulations identified by color as follows: TM1 (blue), TM2 (red), TM4 (purple), and TM5 (orange). Representative TM structures were obtained from the means of all replicas in which interactions were detected. The representative and model structures of TM1--TM2 are shown in (b) and (c), respectively. The representative and model structures of TM4--TM5 are shown in (d) and (e), respectively. Specific interactions were identified in TM1--TM2 simulations (M119^1.39^ with D224^2.50^ and F127^1.47^ with L218^2.44^) and in TM4--TM5 simulations (H411^4.41^ with Q530^5.60^, G415^4.45^ with F525^5.55^, F418^4.48^ with L521^5.51^, and T419^4.49^ with L521^5.51^). [Table [5](#tbl5){ref-type="other"}](#tbl5){ref-type="other"} shows a comparison of the distances between specific atoms in interacting residues of the representative structures and the distances between the same atoms in the model structure.](ct-2016-01246g_0012){#fig12}

###### Comparison of Distance of the Identified Interacting Residues[a](#t5fn1){ref-type="table-fn"} from Contact Matrix Graphs of the Rhodopsin, CXCR4, and β~1~AR Helices and the Crystal Rhodopsin Dimer (1N3M), CXCR4 Dimer (4GPO), and the β~1~AR Dimer (3ODU)

  receptor    helices    interacting residues     crystal structure distance (Å)       mean distance (Å) ± standard deviation
  ----------- ---------- ------------------------ ------------------------------------ ----------------------------------------
  rhodopsin   TM1--TM2   F127^1.47^--L218^2.44^   15.28                                14.2  ±  4.07
                         M119^1.39^--D224^2.50^   9.01                                 10.32  ±  3.1
              TM4--TM5   F418^4.48^--L521^5.51^   12.07                                9.18 ± 3.24
                         T419^4.49^--L521^5.51^   14.77                                8.13 ± 1.96
                         G415^4.45^--F525^5.55^   16.44                                7.5 ± 2.3
                         H411^4.41^--Q530^5.60^   17.64                                9.06 ± 3.34
  CXCR4       TM5--TM5   F201^5.40^--V198^5.37^   7.37                                 15.55 ± 3.34
                         F201^5.40^--Q200^5.39^   11.03                                13.7 ± 1.46
                         F201^5.40^--F201^5.40^   7.91                                 13.6 ± 2.89
                         F201^5.40^--Q202^5.41^   8.72                                 14.93 ± 3.13
                         F201^5.40^--I204^5.43^   12.14                                13.11 ± 3.37
                         F201^5.40^--M205^5.44^   10.6                                 12.6 ± 4.96
  β~1~AR      TM1--TM1   W40^1.31^--A42^1.33^     12.21                                15.28[b](#t5fn2){ref-type="table-fn"}
                         W40^1.31^--S45^1.36^     12.41                                17.5[b](#t5fn2){ref-type="table-fn"}
                         W40^1.31^--L46^1.37^     13.84                                18.3[b](#t5fn2){ref-type="table-fn"}
                         M44^1.35^--L46^1.37^     9.8                                  13.46[b](#t5fn2){ref-type="table-fn"}
                         A49^1.39^--M48^1.38^     8.86                                 5.39[b](#t5fn2){ref-type="table-fn"}
                         L53^1.44^--M48^1.38^     12.19                                5.01[b](#t5fn2){ref-type="table-fn"}
                         L53^1.44^--V51^1.40^     10.75                                4.9[b](#t5fn2){ref-type="table-fn"}
                         L53^1.44^--V52^1.41^     11.13                                5.2[b](#t5fn2){ref-type="table-fn"}
                         L54^1.45^--V51^1.40^     13.9                                 5.09[b](#t5fn2){ref-type="table-fn"}
              TM4--TM5   K159^4.43^--Y231^5.58^   ND[c](#t5fn3){ref-type="table-fn"}   9.01 ± 2.22
                         W166^4.50^--Y227^5.62^   ND[c](#t5fn3){ref-type="table-fn"}   7.9 ± 1.99

Distances are measured from backbone to backbone.

Interactions were detected in only one replica in the ensemble.

Not determined (ND): The distances between TM4 and TM5 could not be measured due to the orientation of the dimer in the 4GPO crystal structure, which is submitted showing the TM1--TM2 dimer interface.

Our studies of CXCR4 identified novel interactions in the homodimer between TM5 and TM5 ([Figure [13](#fig13){ref-type="fig"}](#fig13){ref-type="fig"}). This is similar to what was seen for A~2A~, but the interacting residues in CXCR4 are closer to the extracellular side of the membrane than in A~2A~. A comparison of the mean distance between interacting residues obtained from the simulations with the distance measured between the same residues in the crystal structure shows a similar conservation of distance, particularly between interacting residues further down the helix. This suggests a contribution of the loops for influencing interactions toward the ends of the helices, as was seen for rhodopsin.

![(a) Atomistic structure of the CXCR4 dimer model (3ODU) with the TMs used for simulations identified by color where TM5 is pink. Representative TM structures were obtained from the means of all replicas in which interactions were detected. The representative and model structures of TM5--TM5 are shown in (a) and (b), respectively. Specific interactions were identified in TM5--TM5 simulations (F201^5.40^ with V198^5.37^, Q200^5.39^, F201^5.40^, Q202^5.41^, I204^5.43^, and M205^5.44^). [Table [5](#tbl5){ref-type="other"}](#tbl5){ref-type="other"} shows a comparison of the distances between specific atoms in interacting residues of the representative structures and the distances between the same atoms in the model structure.](ct-2016-01246g_0013){#fig13}

Like rhodopsin, contact interfaces between between TM1 and TM2 ([Figure [14](#fig14){ref-type="fig"}](#fig14){ref-type="fig"}a,b) and between TM4 and TM5 had been proposed for the β~1~ adrenergic receptor. However, using our method it is possible to identify a contact interface between TM1 and TM1 rather than between TM1 and TM2. Our measurements of distance are in agreement with those of the crystal structure. Our data suggest that the TM4--TM5 contact interface, and the four specific amino acids identified within it, may constitute the principal dimer interface in β~1~AR homodimers ([Figure [14](#fig14){ref-type="fig"}](#fig14){ref-type="fig"}c). It was not possible to compare the distances obtained in the TM4--TM5 simulation with those measured in the crystal structure 4GPO, which had been submitted with the orientation of the dimer showing the proposed TM1--TM2 interface.

![(a) Atomistic structure of the β~1~AR dimer model (4GPO) with the TMs used for simulations identified by color as follows: TM1 (pink), TM4 (red), and TM5 (blue). Representative TM structures were obtained from the means of all replicas in which interactions were detected. The representative and model structures of TM1--TM1 are shown in (a) and (b), respectively. The representative and model structures of TM4--TM5 are shown in (c). Specific interactions were identified in TM1--TM1 simulations (W40^1.31^ with A42^1.33^, S45^1.36^, and L46^1.37^; M44^1.35^ with L46^1.37^; A49^1.39^ with M48^1.38^; L53^1.44^ with M48^1.38^; L53^1.44^ with M48^1.38^, V51^1.40^, and V52^1.41^; L54^1.45^ with V51^1.40^) and in TM4--TM5 simulations (K159^4.43^ with Y231^5.58^; W166^4.50^ with Y227^5.62^.). [Table [5](#tbl5){ref-type="other"}](#tbl5){ref-type="other"} shows a comparison of the distances between specific atoms in interacting residues of the representative structures and the distances between the same atoms in the model structure.](ct-2016-01246g_0014){#fig14}

4. Conclusions {#sec4}
==============

In the present study, we have developed and assessed a method of ensemble-based coarse-grained classical molecular dynamics that we have used to predict protein--protein interactions between TM helices of dimeric GPCRs. We applied our method to four different homomeric GPCRs for which experimental data exist and compared our predicted results with published experimental data. We have found that, in each case, the ensemble-based CG-MD methodology provides a reproducible measurement of the distance between interacting helices that corresponds well with the experimental data and is within the range of distances at which protein--protein interactions occur.

The first case was that of the A~2A~ adenosine receptor, which had been shown experimentally to form homodimeric receptors through interactions between the TM5 helices of the two monomers. Our results identified specific interactions involving the P*xxx*M motif of TM5 and, specifically, at the M193^5.54^ residue within that motif. Our method accurately identified residues shown experimentally to be involved in TM5 homodimerization. In parallel with work done experimentally, we investigated the role of M193^5.54^ by characterizing the M193^5.54^A mutation. From this, we identified that the contact interface of the helices was completely changed and that the key interacting residues identified in the wild-type conformation had moved to a new position, preventing the formation of TM5 homodimers. Our results provide a molecular explanation for the experimental finding that the M193^5.54^A mutation alters the monomer:dimer ratio at a level of detail that could not be determined biophysically and would require structural biology studies to confirm experimentally. The second case we examined was that of the rhodopsin dimer for which crystallographic data had identified contact interfaces between TM1 and TM2 and between TM4 and TM5. Ensemble CG-MD confirmed dimerization and the identification of specific interactions within each of these heterologous TM pairs. There is a striking convergence between the distances predicted computationally and those calculated from 1N3M, particularly for specific interactions between TMs 1 and 2, showing that our method is able to provide accurate and precise predictions in agreement with experimental findings. Our method is also able to identify novel interfaces as seen in the third (CXCR4) and fourth (β~1~AR) cases we studied, where we identified a novel interface in CXCR4 between TM5 and TM5 and a novel interface in β~1~AR between TM1 and TM1, in addition to confirming the previously identified contact interface between TM4 and TM5 in β~1~AR. The β~1~AR has been shown to form transient interactions, whereas the β~2~ adrenergic receptor can form stable oligomers.^[@ref62]^ Our ability to detect a stable dimer of TM1--TM1 in the β~1~AR shows the value of ensemble-based simulations for the identification of transient interactions.

We note that, in the four cases we studied, there appears to be a pattern emerging of the nature and location of the contact interfaces. We observe either a single interface, at TM5 in both A~2A~ and CXCR4, or two contact interfaces, as seen in rhodopsin and β~1~AR, one of which involves TM1 and the other which is between TM4 and TM5. Interestingly, interactions in TM5 are observed in both cases. As a greater number of dimeric GPCR crystal structures with corresponding biophysical and functional data become available, the conservation of the pattern we have detected should become clearer.

Our results unequivocally demonstrate that sufficient conformational sampling is required in coarse-grained MD to obtain reproducible and reliable results. In our simulations, we identified that several of the replicas within the ensemble failed to show any interactions and that a number of others began to interact late in the simulation at a point when accurate estimates of distance could no longer be achieved. A single trajectory simulation, particularly if either of these circumstances were to occur, would give inaccurate and potentially misleading results. Indeed, as we have repeatedly emphasized, ensembles are required to obtain accurate and precise results. We used error analysis to determine appropriate choices for ensemble size and run length. For ensemble size, we observed that the rate of change in the standard deviation of the mean distance between helices decreased with increasing replica size and found that approximately 30 replicas were sufficient per ensemble to obtain reproducible results. For run length, we observed that the rate of increase in the standard deviation of the mean distance between helices increased with increasing run length, but that the rate of increase slowed substantially after approximately 300 ns. Interestingly, the negative control we included in our simulations showed no variation in the standard deviation of the mean distance between helices as a function of run length and a low standard deviation with a very rapid decrease to a constant value at an ensemble size of ∼15 replicas. This behavior was notably different from simulations in which interactions were identified and provides a means of confirming the absence of interaction.

In conclusion, we have provided a systematic, reproducible, and reliable protocol for determining the specific points of interaction between GPCR dimers. Our method discriminates between residues in TM helices that form specific interactions and residues that are in close proximity but do not interact. Our work extends the recent findings of ensemble-based fully atomistic MD studies, which have shown that an ensemble-based approach is required to generate predictions of protein properties that correlate well with experimental data.^[@ref83]^ Our method, which is similar in spirit to a recent publication by Wassenaar et al.,^[@ref84]^ is of great utility in further understanding GPCR function and also has broad applicability to many different types of membrane proteins, including receptor tyrosine kinases, ion channels, transporters, and oligomeric complexes of their various combinations.
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